Similar articles

• Metformin.

  Bailey CJ, Turner RC. Bailey CJ, et al. N Engl J Med. 1996 Feb 29;334(9):574-9. doi: 10.1056/NEJM199602293340906. N Engl J Med. 1996. PMID: 8569826 Review. No abstract available.
• Summaries for patients. Metformin for patients with type 2 diabetes mellitus.

  [No authors listed] [No authors listed] Ann Intern Med. 2002 Jul 2;137(1):I50. doi: 10.7326/0003-4819-137-1-200207020-00004. Ann Intern Med. 2002. PMID: 12093266 No abstract available.
• Effect of metformin on various aspects of glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus with varying degrees of hyperglycemia.

  Reaven GM. Reaven GM. Diabetes Metab Rev. 1995 Sep;11 Suppl 1:S97-108. doi: 10.1002/dmr.5610110514. Diabetes Metab Rev. 1995. PMID: 8529491 No abstract available.
• Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients: response to Rosenstock et al.

  Hamid Z, Simmons DL. Hamid Z, et al. Diabetes Care. 2006 Oct;29(10):2331; author reply 2332. doi: 10.2337/dc06-0909. Diabetes Care. 2006. PMID: 17003324 No abstract available.
• Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.

  Goo AK, Carson DS, Bjelajac A. Goo AK, et al. J Fam Pract. 1996 Jun;42(6):612-8. J Fam Pract. 1996. PMID: 8656173 Review.